NO or its derivatives (reactive nitrogen species, RNS) inhibit mitochondrial complex I by several different mechanisms that are not well characterised. There is an inactivation by NO, peroxynitrite and S-nitrosothiols that is reversible by light or reduced thiols, and therefore may be due to S-nitrosation or Fe-nitrosylation of the complex. There is also an irreversible inhibition by peroxynitrite, other oxidants and high levels of NO, which may be due to tyrosine nitration, oxidation of residues or damage of iron sulfur centres. Inactivation of complex I by NO or RNS is seen in cells or tissues expressing iNOS, and may be relevant to inflammatory pathologies, such as septic shock and Parkinson's disease. 
Complex I
Mitochondrial respiratory complex I (NADH:ubiquinone oxidoreductase) is a large and complex enzyme coupling electron transfer to pumping of protons across the mitochondrial inner membrane (reviewed in Refs. [1, 2] ). Bovine heart complex I has been found to contain 45 -46 subunits, FMN, about eight iron -sulfur clusters and one or more ubiquinone binding sites. All cofactors are located on 14 (''core'') subunits that are sufficient for catalysis of energy transduction by complex I. The remaining subunits are thought to be involved in assembly of the complex, in maintaining its stability or in regulation of the activity.
The main function of complex I is transfer of electrons from NADH to ubiquinone in a reaction that is coupled to translocation of protons across the mitochondrial inner membrane. However, recently it has been suggested that complex I might have some additional functions. The SDAP subunit of complex I has been identified as an acyl carrier protein [3] and might be involved in biosynthesis of lipoic acid. There are also three possible links between complex I functions and cell death. Complex I is an important source of production of reactive oxygen species (ROS) [4 -6] . It has also been suggested to be involved in the regulation of mitochondrial permeability transition pore [7] . And finally, the 43rd subunit B16.6 of complex I has been found to be homologous to human GRIM-19 protein which is thought to be a part of the interferon-h-and retinoic acid-induced pathway of cell death [8] .
Little is known about regulation of complex I functions. It has been shown that in vitro complex I undergoes a slow, reversible active/de-active transition and that this transition involves some (as yet non-identified) conformational change [9, 10] . It has also been reported that complex I may be activated by mitochondrial cAMP-dependent protein kinase phosphorylating the 18-kDa subunit of complex I [11] .
Nitric oxide biochemistry
NO is a small molecule, highly diffusible in water and through biological membranes, so NO can easily diffuse from one cell to the next. The main source of NO within the cells is synthesis by three isoforms of NO synthase: two constitutively expressed isoenzymes eNOS and nNOS and the third, iNOS, which is induced during inflammation and produces higher levels of NO for a longer period [12] . There may also be a mitochondrial NOS (mtNOS), whose origin and status is still unclear, but if mtNOS exists is probably derived from eNOS, iNOS or nNOS [13, 14] . NO may also be produced nonenzymatically from nitrite at low pH ( < pH 5), e.g. during ischaemia [15] .
NO itself at physiological concentrations (unclear, but probably 0.1 -100 nM) is relatively unreactive, and most of its physiological actions are mediated by NO binding to Fe 2 + in the haem of soluble guanylate cyclase causing activation and cGMP production [12] . NO may also bind with high affinity to free Fe 2 + or Fe 2 + within any other haem protein with a free ligand position, such as cytochrome c oxidase or catalase. However, NO may be converted to a number of more reactive derivatives, known collectively as reactive nitrogen species (RNS) (Fig. 1 
NO effects on mitochondria
NO and RNS inhibit mitochondrial respiration by different means: (A) NO itself causes rapid, selective, potent, but reversible inhibition of cytochrome oxidase, and (B) RNS cause slow, nonselective, weak, but irreversible inhibition of many mitochondrial components [16 -18] . The reversible NO inhibition of cytochrome oxidase occurs at nanomolar levels of NO and in competition with oxygen [19 -21] , so that NO is potentially a physiological regulator of respiration [22, 23] . Peroxynitrite can inhibit complex I, complex II, cytochrome oxidase (complex IV), the ATP synthase, aconitase, Mn-SOD, creatine kinase, and probably many other proteins [16, 18, 24] . Peroxynitrite is a strong oxidant and can also induce lipid peroxidation and increase mito- chondrial proton (and other ion) permeability (probably by lipid peroxidation or thiol cross-linking) [24] . Apart from inhibiting respiration, NO has two other relevant effects on mitochondria: (1) induction of ROS and RNS production from mitochondria [25] , and (2) induction of mitochondrial permeability transition by RNS [26, 27] .
Mechanisms of NO inhibition of complex I
NO/RNS might inhibit complex I by several different mechanisms, some of which have supporting evidence and some are speculative: (i) release of iron from complex I iron -sulfur (FeS) centres, (ii) reversible modification of Fe, S or cysteine in FeS centres, (iii) S-nitrosation of cysteine residues, (iv) oxidation of cysteine residues, (v) glutathionylation of cysteine residues, (vi) N-nitrosation of secondary amines, e.g. in tryptophan residues, (vii) oxidation of tryptophan residues, (viii) nitration of tyrosine residues, (ix) modification of coenzymes NADH, ubiquinone or FMN, or (x) oxidation of phospholipids. Inhibition could be mediated by NO itself, any of the RNS: ONOO 
Discovery of macrophage NO and its role in cytostasis/ cytotoxicity of tumour cells
Historically the first reported complex I inhibition attributable to NO predates the discovery of biological NO, and contributed to that discovery [28 -31] . Inflammatory-activated macrophages were found to inhibit complex I (as well as complex II and aconitase, but not other complexes) within co-cultured tumour cells or cell lines or the macrophages themselves, and the inhibition depended on the presence of L-arginine (substrate of NO synthase) [28 -31] . NO itself was subsequently found to cause complex I inhibition within these cells, leading to the conclusion that NO derived from the macrophages was inhibiting complex I within the tumour cells [30] . That the respiratory inhibition (by whatever mechanisms) mediated the killing and/or cytostasis of tumour cells was suggested by the finding that tumour cell death could be completely prevented by glucose acting presumably as substrate for glycolysis and thus an alternative source of ATP [31] .
Damage to FeS centres
The inhibition of complex I, complex II and aconitase induced by NO from the macrophages was attributed to NOinduced damage to iron -sulfur centres and the release of iron from these centres [29, 31] . Cells exposed to NO or NO from iNOS were subsequently found to exhibit a g = 2.04 electron paramagnetic resonance (EPR) signal characteristic of dinitrosyl iron complexes Fe(NO) 2 (SR) 2 [32] , suggesting that the iron was removed from susceptible iron sulfur centres by NO reacting directly with the iron, displacing elemental sulfur or cysteine residues (Fig. 1C) . However, it was never shown that the dinitrosyl iron complex appearing in NO-exposed cells was derived from mitochondrial ironsulfur centres, and indeed on quantitative grounds this seemed unlikely.
Despite the lack of direct evidence that NO can remove iron from iron -sulfur centres in complex I, it is clear that NO can displace iron from other iron -sulfur centres, and understanding how this occurs mechanistically may be of some relevance to the actions of NO on complex I. High concentrations of NO can destroy iron -sulfur centres by binding and displacing the iron as dinitrosyl iron, and there is EPR evidence for such damage in complex II [33] , but not so far in complex I. Reversible NO inactivation of E. coli exonuclease III, ferredoxin and other iron -sulfur proteins has been shown to be mediated by disruption of the ironsulfur centre to form a dinitrosyl iron complex (Fig. 1C) , which can be reconverted to the functional iron -sulfur centre by reduced thiols [34] . NO can cause inactivation of aconitase in some conditions that may involve catalytic S-nitrosation of the iron -sulfur centre [35] . Peroxynitrite can more rapidly inactivate aconitase via removal of one particular labile iron atom of the active site 4Fe4S ironsulfur centre [36] . We might speculate that damage to complex I iron -sulfur centres may start with NO reacting with the iron (to form dinitrosyl iron), and/or the sulfide or cysteine residues that bind the iron (to form RSNO) (Fig.  1C) . This initial phase of inhibition may be reversible by light or reduced thiols, but further reactions with the Fe or S may completely disassemble the iron -sulfur centres and thus irreversibly inhibit activity.
S-nitrosation of complex I
More recently, it was found that several cell types exposed to NO for several hours developed an irreversible inhibition of cellular respiration due specifically to inactivation of complex I [23, 37] . However, this inactivation of complex I and respiration was completely reversed by either light or reduced thiols, suggesting that the inactivation was due to S-nitrosation of complex I (as S-nitrosation is generally reversed by these treatments). This was an important finding as it indicated: (a) that NO inhibition of cellular respiration was mainly due to complex I inhibition, and (b) the inhibition was reversible by specific agents indicating potential mechanisms. However, there is no direct evidence for S-nitrosation of complex I as yet, and reduced thiols and light might potentially reverse other forms of NO inhibition such as nitrosylation of iron.
The S-nitrosothiols: S-nitrosoglutathione (SNOG) and S-nitrosoacetylpenicillamine (SNAP) can rapidly inactivate complex I when added to isolated mitochondria, even in conditions when little or no NO is released, and such inhibition is reversed by light or reduced thiols (glutathione or dithiothreitol), suggesting that the inactivation is mediated by transnitrosation [38] . However, the inhibition of complex I induced by peroxynitrite (which is regarded as a poor S-nitrosating agent) is also partly reversed by light and reduced thiols [38] , suggesting that mechanisms other than nitrosation might be involved or that peroxynitrite may nitrosate. Recently we found that NO and calcium synergistically inhibited the complex I activity and oxygen consumption of isolated mitochondria [39] . This inhibition was prevented by superoxide dismutase or urate, suggesting that the inhibition was mediated by peroxynitrite. And the inhibition was reversed by reduced thiols or light suggesting that the inhibition (although mediated by peroxynitrite) may involve S-nitrosation or Fe-nitrosylation of complex I [39] .
Tyrosine nitration by peroxynitrite
Long-term exposure of isolated mitochondria or submitochodrial particles was reported to result in relatively specific inhibition of complex I that was partially prevented by superoxide dismutase or urate (a superoxide and peroxynitrite scavenger) implicating peroxynitrite as mediating the inhibition [40] . The inhibition was not reversed by reduced glutathione, suggesting S-nitrosation was not involved, but was accompanied by tyrosine nitration of complex I subunits, suggesting that nitration may mediate the inhibition [40] .
Others have also suggested that peroxynitrite inhibits complex I by tyrosine nitration [41, 42] . Addition of 0.2 -2.0 mM peroxynitrite to isolated mitochondria has been shown by several groups to result in inhibition of complex I, complex II and complex V (the ATP synthase) with relatively little affect on complexes III and IV [18, 41, 43, 44] . Accompanying such inhibition there was tyrosine nitration of five complex I peptides: the 49-kDa subunit (NDUFS2), TYHY (NDUFS8), B17.2 (17.2-kDa differentiation associated protein), B15 (NDUFB4) and B14 (NDUFA6). However, the estimated level of nitration was low (a few percent) except on peptides B14 and B15, and these peptides are not thought to be involved in complex I respiratory activity [42] . So it is still unclear whether tyrosine nitration mediates peroxynitrite-induced inhibition of complex I.
Evidence of tyrosine nitration of mitochondrial complex I subunits was found in an untreated dopaminergic SH-SY5Y ''neuronal'' cell line using an antibody against protein-bound 3-nitro tyrosine [41] . ONOO À generating SIN-1 induced apoptosis in these cells with concomitant increase in tyrosine nitration and reduction in mitochondrial ATP synthesis. These results suggest that ONOO À may induce mitochondrial dysfunction and cell death in neurons through nitration of mitochondrial complex I subunits [41] .
Other thiol modifications
Exposure of mitochondria or isolated complex I to SNAP or oxidised glutathione (GSSG) resulted in blockage of reduced thiols specifically on the 51-kDa and 75-kDa subunits of complex I, which might result from S-nitrosation, oxidation or glutathionylation of cysteine residues [45] . This thiol modification correlated in time with inhibition of complex I activity, but while thiol modification was reversed by dithiothreitol and GSH, the inhibition was not [45] , suggesting either that the thiol modification is not involved in inhibition or that thiol modification proceeds from a reversible to an irreversible form.
Addition of peroxynitrite to mitochondria resulted in the oxidation of a methionine and a tryptophan residue in the B17.2 (DAP) subunit of complex I, although the extent of oxidation was not quantified, and it is unclear whether such modification in this subunit could inhibit complex activity [42] .
Pathological relevance of NO inhibition of complex I
Whatever the mechanism, NO inhibition of complex I may be important in cell pathology and disease. A decrease in complex I activity and ATP levels has been observed in skeletal muscle biopsies from critically ill patients in septic shock; the decrease in complex I activity correlated with increased clinical severity and NO production (and decreased GSH levels), and was suggested to be causative in the pathology [46] . A rat model of septic shock reproduced these findings in both skeletal muscle and liver [47] .
Parkinson's disease results from degeneration of dopaminergic neurons in the substantia nigra of the brain. Degeneration is accompanied by substantial inhibition of complex I activity in these cells, and complex I inhibitors can result in symptoms similar or identical to the disease, leading to the suggestion that complex I inhibition in the cells leads to their degeneration and hence the disease [48] . NO or RNS, derived from inflammatory activated glia, have been suggested as potential mediators of this complex I inhibition [48] , however, there is no direct evidence for this. Inflammatory activation of a microglial (brain macrophage) cell line resulted in iNOS expression and inhibition of mitochondrial respiratory complexes I and II and aconitase, which was prevented by iNOS inhibition [49] . However, it was found that coculture of primary forebrain neurons with iNOS-expressing astrocytes did not cause complex I inactivation, unless cellular glutathione was depleted, suggesting that glutathione protects complex I from NO-induced inhibition [50] . Other authors found that dopamine synergised with NO to inhibit complex I in PC12 cells for reasons that are unclear, but this may indicate that dopaminergic neurons are more susceptible to NO inhibition of complex I [51] .
Emotional stress also induced iNOS in rat brain, and caused substantial inhibition of the apparent brain activities of mitochondrial complexes I and II, which was prevented by an iNOS inhibitor, suggesting that NO from iNOS may inhibit mitochondrial complex activities in vivo [52] .
Conclusions
At least three mechanisms have been invoked in the NO inhibition of complex I: S-nitrosation, tyrosine nitration and damage to FeS centres. None of these mechanisms has been definitively shown to mediate inhibition, although it is likely that all three mechanisms, as well as others, occur. In some conditions the NO inhibition of complex I is reversible by light or reduced thiols, and this may indicate S-nitrosation or Fe-nitrosylation. The inhibition of complex I appears to be one of the most important means of NO-induced inhibition of cellular respiration, at least in some conditions, although other mitochondrial components are also inhibited. iNOSexpressing cells and tissues exhibit an inhibition of complex I, which might contribute to inflammatory pathology for example in Parkinson's disease and septic shock.
